# Instacart timeline

entity: /record/instacart.md  
id: ent_instacart  


## undated

- undated | state_of_incorporation | DE | valid | [clm_2792F6CC42C0](/claim/clm_2792F6CC42C0.md)
- undated | cik | 0001579091 | valid | [clm_4C70E684467D](/claim/clm_4C70E684467D.md)
- undated | fiscal_year_end | 12-31 | valid | [clm_4FE64D324074](/claim/clm_4FE64D324074.md)
- undated | sic_industry | Services-Business Services, NEC (7389) | valid | [clm_537EB93C80E4](/claim/clm_537EB93C80E4.md)
- undated | registrant_name | Maplebear Inc. | valid | [clm_D51524B5CA82](/claim/clm_D51524B5CA82.md)
- undated | ticker | CART | valid | [clm_EB51D1B0F27E](/claim/clm_EB51D1B0F27E.md)
- undated to 2023-09-19 | legal_form | privately held company | superseded | [clm_20F6B0152538](/claim/clm_20F6B0152538.md)
- undated to 2023-09-19 | legal_form | public company | superseded | [clm_3997FDABBCDF](/claim/clm_3997FDABBCDF.md)
- undated | headquarters | San Francisco | unverified | [clm_8DF359F66A3B](/claim/clm_8DF359F66A3B.md)
- undated | website | https://instacart.com/ | unverified | [clm_E4FE76764CAE](/claim/clm_E4FE76764CAE.md)

## 2012

- 2012-06-25 | x_username | Instacart | unverified | [clm_4708866E0B3E](/claim/clm_4708866E0B3E.md)

## 2020

- 2020-12-31 to 2021-12-31 | total_equity | -981,000,000 United States dollar | superseded | [clm_EBF30CC22FBB](/claim/clm_EBF30CC22FBB.md)

## 2021

- 2021-01-01 to 2025-08-15 | ceo | Fidji Simo | superseded | [clm_732BE8D9D616](/claim/clm_732BE8D9D616.md)
- 2021-12-31 to 2022-12-31 | revenue | 1,834,000,000 United States dollar | superseded | [clm_820473D76A5D](/claim/clm_820473D76A5D.md)
- 2021-12-31 to 2022-09-30 | cash_and_equivalents | 1,146,000,000 United States dollar | superseded | [clm_A95AF4D5FC25](/claim/clm_A95AF4D5FC25.md)
- 2021-12-31 to 2022-03-31 | total_equity | -573,000,000 United States dollar | superseded | [clm_BB77238D2D27](/claim/clm_BB77238D2D27.md)
- 2021-12-31 to 2022-12-31 | net_income | -73,000,000 United States dollar | superseded | [clm_D6AC6E4F250E](/claim/clm_D6AC6E4F250E.md)
- 2021-12-31 to 2022-12-31 | research_and_development | 368,000,000 United States dollar | superseded | [clm_DC6D75EA8162](/claim/clm_DC6D75EA8162.md)
- 2021-12-31 to 2022-12-31 | operating_income | -86,000,000 United States dollar | superseded | [clm_E6FD92DC0BAA](/claim/clm_E6FD92DC0BAA.md)

## 2022

- 2022-03-31 to 2022-06-30 | total_equity | -611,000,000 United States dollar | superseded | [clm_69489ABAADB9](/claim/clm_69489ABAADB9.md)
- 2022-03-31 to 2022-06-30 | quarterly_net_income | -82,000,000 United States dollar | superseded | [clm_FEDE7008E82C](/claim/clm_FEDE7008E82C.md)
- 2022-06-30 to 2022-09-30 | total_equity | -603,000,000 United States dollar | superseded | [clm_C14D313049BF](/claim/clm_C14D313049BF.md)
- 2022-06-30 to 2022-09-30 | quarterly_net_income | 8,000,000 United States dollar | superseded | [clm_F4A3FC4F6500](/claim/clm_F4A3FC4F6500.md)
- 2022-09-30 to 2022-12-31 | total_equity | -563,000,000 United States dollar | superseded | [clm_214EFA5127F2](/claim/clm_214EFA5127F2.md)
- 2022-09-30 to 2023-03-31 | quarterly_revenue | 668,000,000 United States dollar | superseded | [clm_2B66D8C1EE56](/claim/clm_2B66D8C1EE56.md)
- 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 127,000,000 United States dollar | superseded | [clm_49D7E272EFF8](/claim/clm_49D7E272EFF8.md)
- 2022-09-30 to 2023-03-31 | quarterly_operating_income | 33,000,000 United States dollar | superseded | [clm_CAB0CE44F7E0](/claim/clm_CAB0CE44F7E0.md)
- 2022-09-30 to 2023-03-31 | quarterly_net_income | 36,000,000 United States dollar | superseded | [clm_F3E717477ABD](/claim/clm_F3E717477ABD.md)
- 2022-09-30 to 2022-12-31 | cash_and_equivalents | 1,472,000,000 United States dollar | superseded | [clm_FC5F762EF83D](/claim/clm_FC5F762EF83D.md)
- 2022-12-31 to 2023-12-31 | revenue | 2,551,000,000 United States dollar | superseded | [clm_2367ADE960D4](/claim/clm_2367ADE960D4.md)
- 2022-12-31 to 2023-03-31 | total_equity | -64,000,000 United States dollar | superseded | [clm_6567640D183B](/claim/clm_6567640D183B.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 518,000,000 United States dollar | superseded | [clm_A2D05E33EDC4](/claim/clm_A2D05E33EDC4.md)
- 2022-12-31 to 2023-12-31 | operating_income | 62,000,000 United States dollar | superseded | [clm_BCB2BA08E01C](/claim/clm_BCB2BA08E01C.md)
- 2022-12-31 to 2023-09-30 | total_assets | 3,669,000,000 United States dollar | superseded | [clm_BF7F659EA7F8](/claim/clm_BF7F659EA7F8.md)
- 2022-12-31 to 2023-03-31 | cash_and_equivalents | 1,505,000,000 United States dollar | superseded | [clm_C4C39E12A8C2](/claim/clm_C4C39E12A8C2.md)
- 2022-12-31 to 2023-12-31 | net_income | 428,000,000 United States dollar | superseded | [clm_FA46B9E30BB7](/claim/clm_FA46B9E30BB7.md)

## 2023

- 2023-01-01 | listed_on | Nasdaq | valid | [clm_C9B70A0F5F1D](/claim/clm_C9B70A0F5F1D.md)
- 2023-03-31 to 2023-06-30 | cash_and_equivalents | 1,616,000,000 United States dollar | superseded | [clm_1EEC9047F420](/claim/clm_1EEC9047F420.md)
- 2023-03-31 to 2023-06-30 | total_equity | 70,000,000 United States dollar | superseded | [clm_7F74387F0BEE](/claim/clm_7F74387F0BEE.md)
- 2023-03-31 to 2023-06-30 | quarterly_net_income | 128,000,000 United States dollar | superseded | [clm_C20988D50580](/claim/clm_C20988D50580.md)
- 2023-03-31 to 2023-06-30 | quarterly_revenue | 759,000,000 United States dollar | superseded | [clm_C4FF18536163](/claim/clm_C4FF18536163.md)
- 2023-03-31 to 2023-06-30 | quarterly_operating_income | 150,000,000 United States dollar | superseded | [clm_CE0771298DB4](/claim/clm_CE0771298DB4.md)
- 2023-06-30 to 2023-09-30 | quarterly_revenue | 716,000,000 United States dollar | superseded | [clm_3752A16527F3](/claim/clm_3752A16527F3.md)
- 2023-06-30 to 2023-09-30 | quarterly_operating_income | 119,000,000 United States dollar | superseded | [clm_44A82DF2D3AF](/claim/clm_44A82DF2D3AF.md)
- 2023-06-30 to 2023-09-30 | cash_and_equivalents | 1,838,000,000 United States dollar | superseded | [clm_89BDFD8A8F7A](/claim/clm_89BDFD8A8F7A.md)
- 2023-06-30 to 2023-09-30 | quarterly_net_income | 114,000,000 United States dollar | superseded | [clm_8E9CBB2F3973](/claim/clm_8E9CBB2F3973.md)
- 2023-06-30 to 2023-09-30 | total_equity | 191,000,000 United States dollar | superseded | [clm_BE57140A7361](/claim/clm_BE57140A7361.md)
- 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 130,000,000 United States dollar | superseded | [clm_C6A9BB49B6EB](/claim/clm_C6A9BB49B6EB.md)
- 2023-09-19 | legal_form | initial public offering | unverified | [clm_C33E369D1A3E](/claim/clm_C33E369D1A3E.md)
- 2023-09-22 | board_member | Ravi Gupta | valid | [clm_FE82C3446189](/claim/clm_FE82C3446189.md)
- 2023-09-30 to 2023-12-31 | cash_and_equivalents | 2,010,000,000 United States dollar | superseded | [clm_126857B4BF7D](/claim/clm_126857B4BF7D.md)
- 2023-09-30 to 2024-03-31 | quarterly_revenue | 764,000,000 United States dollar | superseded | [clm_26ABEDB621E0](/claim/clm_26ABEDB621E0.md)
- 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 1,850,000,000 United States dollar | superseded | [clm_50E28536AC69](/claim/clm_50E28536AC69.md)
- 2023-09-30 to 2024-03-31 | quarterly_net_income | -1,999,000,000 United States dollar | superseded | [clm_6932B4D0975C](/claim/clm_6932B4D0975C.md)
- 2023-09-30 to 2023-12-31 | total_equity | 3,484,000,000 United States dollar | superseded | [clm_6A47B21E525F](/claim/clm_6A47B21E525F.md)
- 2023-09-30 to 2024-03-31 | quarterly_operating_income | -2,457,000,000 United States dollar | superseded | [clm_A2E1F00D767B](/claim/clm_A2E1F00D767B.md)
- 2023-09-30 to 2023-12-31 | total_assets | 4,421,000,000 United States dollar | superseded | [clm_A761F6F62D31](/claim/clm_A761F6F62D31.md)
- 2023-10-31 to 2024-02-29 | shares_outstanding | 280,215,950 shares | superseded | [clm_5633F03E4FDC](/claim/clm_5633F03E4FDC.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 2,312,000,000 United States dollar | superseded | [clm_047B6DCF73DD](/claim/clm_047B6DCF73DD.md)
- 2023-12-31 to 2024-12-31 | revenue | 3,042,000,000 United States dollar | superseded | [clm_5D5A55C3F021](/claim/clm_5D5A55C3F021.md)
- 2023-12-31 to 2024-12-31 | net_income | -1,622,000,000 United States dollar | superseded | [clm_5DBF7A89895F](/claim/clm_5DBF7A89895F.md)
- 2023-12-31 to 2024-03-31 | cash_and_equivalents | 2,137,000,000 United States dollar | superseded | [clm_6543F3D3510B](/claim/clm_6543F3D3510B.md)
- 2023-12-31 to 2024-12-31 | operating_income | -2,142,000,000 United States dollar | superseded | [clm_8FCA48A3E39A](/claim/clm_8FCA48A3E39A.md)
- 2023-12-31 to 2024-03-31 | total_assets | 4,727,000,000 United States dollar | superseded | [clm_DC17937AAF96](/claim/clm_DC17937AAF96.md)
- 2023-12-31 to 2024-03-31 | total_equity | 3,750,000,000 United States dollar | superseded | [clm_FF2293E81ABB](/claim/clm_FF2293E81ABB.md)

## 2024

- 2024-02-29 to 2024-04-30 | shares_outstanding | 266,498,832 shares | superseded | [clm_A4D9295F830F](/claim/clm_A4D9295F830F.md)
- 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 115,000,000 United States dollar | superseded | [clm_47FEF1428C1C](/claim/clm_47FEF1428C1C.md)
- 2024-03-31 to 2024-06-30 | total_equity | 3,141,000,000 United States dollar | superseded | [clm_6C344641E196](/claim/clm_6C344641E196.md)
- 2024-03-31 to 2024-06-30 | quarterly_operating_income | 144,000,000 United States dollar | superseded | [clm_8609D59A48E4](/claim/clm_8609D59A48E4.md)
- 2024-03-31 to 2024-06-30 | quarterly_net_income | 130,000,000 United States dollar | superseded | [clm_8E2E77FC0C41](/claim/clm_8E2E77FC0C41.md)
- 2024-03-31 to 2024-06-30 | total_assets | 4,097,000,000 United States dollar | superseded | [clm_95D77F09A709](/claim/clm_95D77F09A709.md)
- 2024-03-31 to 2024-06-30 | cash_and_equivalents | 1,514,000,000 United States dollar | superseded | [clm_E0CFBFC07689](/claim/clm_E0CFBFC07689.md)
- 2024-03-31 to 2024-06-30 | quarterly_revenue | 820,000,000 United States dollar | superseded | [clm_E97533C58BA4](/claim/clm_E97533C58BA4.md)
- 2024-04-12 | board_member | Victoria Dolan | valid | [clm_4433A5C43B16](/claim/clm_4433A5C43B16.md)
- 2024-04-30 to 2024-07-31 | shares_outstanding | 264,699,304 shares | superseded | [clm_92C01B0F9FD7](/claim/clm_92C01B0F9FD7.md)
- 2024-05-07 | cfo | Emily Reuter | valid | [clm_6A1EF0D25BAA](/claim/clm_6A1EF0D25BAA.md)
- 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 185,000,000 United States dollar | superseded | [clm_34F73FB376C1](/claim/clm_34F73FB376C1.md)
- 2024-06-30 to 2024-09-30 | quarterly_revenue | 823,000,000 United States dollar | superseded | [clm_622DC1B90AEB](/claim/clm_622DC1B90AEB.md)
- 2024-06-30 to 2024-09-30 | quarterly_net_income | 61,000,000 United States dollar | superseded | [clm_A38D8CC62AB7](/claim/clm_A38D8CC62AB7.md)
- 2024-06-30 to 2024-09-30 | total_equity | 3,039,000,000 United States dollar | superseded | [clm_AAEF490142AE](/claim/clm_AAEF490142AE.md)
- 2024-06-30 to 2024-09-30 | total_assets | 4,027,000,000 United States dollar | superseded | [clm_ACD9FDFBE3D7](/claim/clm_ACD9FDFBE3D7.md)
- 2024-06-30 to 2024-09-30 | quarterly_operating_income | 52,000,000 United States dollar | superseded | [clm_BF1B75CCF4C0](/claim/clm_BF1B75CCF4C0.md)
- 2024-06-30 to 2024-09-30 | cash_and_equivalents | 1,434,000,000 United States dollar | superseded | [clm_FBFF3ECE3902](/claim/clm_FBFF3ECE3902.md)
- 2024-07-31 to 2024-10-31 | shares_outstanding | 260,804,661 shares | superseded | [clm_DFC5E64548C9](/claim/clm_DFC5E64548C9.md)
- 2024-08-16 | board_member | Mary Beth Laughton | valid | [clm_C0A7FCFC7E58](/claim/clm_C0A7FCFC7E58.md)
- 2024-09-30 to 2025-03-31 | quarterly_net_income | 118,000,000 United States dollar | superseded | [clm_2EFA9E429D0A](/claim/clm_2EFA9E429D0A.md)
- 2024-09-30 to 2025-03-31 | quarterly_operating_income | 138,000,000 United States dollar | superseded | [clm_4C8E704B595D](/claim/clm_4C8E704B595D.md)
- 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 149,000,000 United States dollar | superseded | [clm_5C1919D0B4A8](/claim/clm_5C1919D0B4A8.md)
- 2024-09-30 to 2025-03-31 | quarterly_revenue | 852,000,000 United States dollar | superseded | [clm_68B201FA6531](/claim/clm_68B201FA6531.md)
- 2024-09-30 to 2024-12-31 | total_assets | 3,926,000,000 United States dollar | superseded | [clm_8B999C4F3235](/claim/clm_8B999C4F3235.md)
- 2024-09-30 to 2024-12-31 | cash_and_equivalents | 1,288,000,000 United States dollar | superseded | [clm_BBB97BA4A0C9](/claim/clm_BBB97BA4A0C9.md)
- 2024-09-30 to 2024-12-31 | total_equity | 2,872,000,000 United States dollar | superseded | [clm_D7780E1A7182](/claim/clm_D7780E1A7182.md)
- 2024-10-31 to 2025-02-21 | shares_outstanding | 256,894,776 shares | superseded | [clm_012BFC2C6538](/claim/clm_012BFC2C6538.md)
- 2024-12-31 to 2025-03-31 | total_assets | 4,115,000,000 United States dollar | superseded | [clm_1A9ABBF7AE22](/claim/clm_1A9ABBF7AE22.md)
- 2024-12-31 to 2025-03-31 | total_equity | 3,093,000,000 United States dollar | superseded | [clm_2009D6D333EA](/claim/clm_2009D6D333EA.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 604,000,000 United States dollar | superseded | [clm_27EC4E953FCA](/claim/clm_27EC4E953FCA.md)
- 2024-12-31 to 2025-12-31 | net_income | 457,000,000 United States dollar | superseded | [clm_299C3172C420](/claim/clm_299C3172C420.md)
- 2024-12-31 to 2025-12-31 | operating_income | 489,000,000 United States dollar | superseded | [clm_668E4C59EE7E](/claim/clm_668E4C59EE7E.md)
- 2024-12-31 to 2025-03-31 | cash_and_equivalents | 1,278,000,000 United States dollar | superseded | [clm_8DFDF73865E3](/claim/clm_8DFDF73865E3.md)
- 2024-12-31 to 2025-12-31 | revenue | 3,378,000,000 United States dollar | superseded | [clm_AA7C4B004E4F](/claim/clm_AA7C4B004E4F.md)

## 2025

- 2025-02-21 to 2025-04-30 | shares_outstanding | 264,642,275 shares | superseded | [clm_EF296345FB47](/claim/clm_EF296345FB47.md)
- 2025-03-31 to 2025-06-30 | quarterly_net_income | 106,000,000 United States dollar | superseded | [clm_024C6FFC4F0F](/claim/clm_024C6FFC4F0F.md)
- 2025-03-31 to 2025-06-30 | quarterly_operating_income | 110,000,000 United States dollar | superseded | [clm_14E9708A4E8D](/claim/clm_14E9708A4E8D.md)
- 2025-03-31 to 2025-06-30 | quarterly_revenue | 897,000,000 United States dollar | superseded | [clm_19172414D64A](/claim/clm_19172414D64A.md)
- 2025-03-31 to 2025-06-30 | total_assets | 4,292,000,000 United States dollar | superseded | [clm_5957C839C983](/claim/clm_5957C839C983.md)
- 2025-03-31 to 2025-06-30 | total_equity | 3,176,000,000 United States dollar | superseded | [clm_6917A46A3BB6](/claim/clm_6917A46A3BB6.md)
- 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 144,000,000 United States dollar | superseded | [clm_7C45269A151A](/claim/clm_7C45269A151A.md)
- 2025-03-31 to 2025-06-30 | cash_and_equivalents | 1,558,000,000 United States dollar | superseded | [clm_C97E871E5AD2](/claim/clm_C97E871E5AD2.md)
- 2025-04-30 to 2025-07-31 | shares_outstanding | 260,734,689 shares | superseded | [clm_76A51B5A815A](/claim/clm_76A51B5A815A.md)
- 2025-06-30 to 2025-09-30 | cash_and_equivalents | 1,489,000,000 United States dollar | superseded | [clm_01D4EBD1A361](/claim/clm_01D4EBD1A361.md)
- 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 166,000,000 United States dollar | superseded | [clm_1B71D3C156AE](/claim/clm_1B71D3C156AE.md)
- 2025-06-30 to 2025-09-30 | total_equity | 3,299,000,000 United States dollar | superseded | [clm_2B3656AC3AC1](/claim/clm_2B3656AC3AC1.md)
- 2025-06-30 to 2025-09-30 | total_assets | 4,433,000,000 United States dollar | superseded | [clm_35767CFDB02C](/claim/clm_35767CFDB02C.md)
- 2025-06-30 to 2025-09-30 | quarterly_revenue | 914,000,000 United States dollar | superseded | [clm_9984003014DD](/claim/clm_9984003014DD.md)
- 2025-06-30 to 2025-09-30 | quarterly_operating_income | 124,000,000 United States dollar | superseded | [clm_B239FDAC993B](/claim/clm_B239FDAC993B.md)
- 2025-06-30 to 2025-09-30 | quarterly_net_income | 116,000,000 United States dollar | superseded | [clm_C1C4E5F97317](/claim/clm_C1C4E5F97317.md)
- 2025-07-31 to 2025-10-31 | shares_outstanding | 263,438,274 shares | superseded | [clm_5316F0DEAEDE](/claim/clm_5316F0DEAEDE.md)
- 2025-08-15 | board_member | Chris Rogers | valid | [clm_07FC16ED34BA](/claim/clm_07FC16ED34BA.md)
- 2025-08-15 | president | Chris Rogers | valid | [clm_2663125928A3](/claim/clm_2663125928A3.md)
- 2025-08-15 | ceo | Chris Rogers | valid | [clm_44ADBDA2E7D1](/claim/clm_44ADBDA2E7D1.md)
- 2025-08-15 | board_member | Josh Silverman | valid | [clm_E5179549C15D](/claim/clm_E5179549C15D.md)
- 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 169,000,000 United States dollar | superseded | [clm_00BD162B7372](/claim/clm_00BD162B7372.md)
- 2025-09-30 to 2026-03-31 | quarterly_revenue | 939,000,000 United States dollar | superseded | [clm_0EAD91BC96EB](/claim/clm_0EAD91BC96EB.md)
- 2025-09-30 to 2026-03-31 | quarterly_net_income | 144,000,000 United States dollar | superseded | [clm_6543EA40747E](/claim/clm_6543EA40747E.md)
- 2025-09-30 to 2025-12-31 | total_equity | 3,458,000,000 United States dollar | superseded | [clm_88DFA2113345](/claim/clm_88DFA2113345.md)
- 2025-09-30 to 2025-12-31 | cash_and_equivalents | 1,690,000,000 United States dollar | superseded | [clm_91658C26C658](/claim/clm_91658C26C658.md)
- 2025-09-30 to 2026-03-31 | quarterly_operating_income | 166,000,000 United States dollar | superseded | [clm_934D97F6EF8A](/claim/clm_934D97F6EF8A.md)
- 2025-09-30 to 2025-12-31 | total_assets | 4,540,000,000 United States dollar | superseded | [clm_F66A97F40982](/claim/clm_F66A97F40982.md)
- 2025-10-31 to 2026-02-20 | shares_outstanding | 262,532,964 shares | superseded | [clm_9A96F6D33A9B](/claim/clm_9A96F6D33A9B.md)
- 2025-11-24 | chair | Chris Rogers | valid | [clm_40FE32AA0ED9](/claim/clm_40FE32AA0ED9.md)
- 2025-12-31 to 2026-03-31 | total_equity | 2,518,000,000 United States dollar | superseded | [clm_3A3E79D5F354](/claim/clm_3A3E79D5F354.md)
- 2025-12-31 to 2026-03-31 | cash_and_equivalents | 637,000,000 United States dollar | superseded | [clm_5B4C68A7BE95](/claim/clm_5B4C68A7BE95.md)
- 2025-12-31 | operating_income | 498,000,000 United States dollar | valid | [clm_7A790E0C8203](/claim/clm_7A790E0C8203.md)
- 2025-12-31 | net_income | 447,000,000 United States dollar | valid | [clm_87808C4834C1](/claim/clm_87808C4834C1.md)
- 2025-12-31 | revenue | 3,742,000,000 United States dollar | valid | [clm_9187ADE3A8F9](/claim/clm_9187ADE3A8F9.md)
- 2025-12-31 | research_and_development | 650,000,000 United States dollar | valid | [clm_95A1C0C11EEF](/claim/clm_95A1C0C11EEF.md)
- 2025-12-31 to 2026-03-31 | total_assets | 3,687,000,000 United States dollar | superseded | [clm_CE0897C6075A](/claim/clm_CE0897C6075A.md)

## 2026

- 2026-02-20 to 2026-04-30 | shares_outstanding | 240,615,063 shares | superseded | [clm_74FF479DAD89](/claim/clm_74FF479DAD89.md)
- 2026-03-31 to 2026-06-30 | quarterly_revenue | 1,019,000,000 United States dollar | superseded | [clm_1EC0EE6060D7](/claim/clm_1EC0EE6060D7.md)
- 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 164,000,000 United States dollar | superseded | [clm_B8EE839814E6](/claim/clm_B8EE839814E6.md)
- 2026-03-31 to 2026-06-30 | cash_and_equivalents | 631,000,000 United States dollar | superseded | [clm_BEE53E66FE5B](/claim/clm_BEE53E66FE5B.md)
- 2026-03-31 to 2026-06-30 | quarterly_operating_income | 182,000,000 United States dollar | superseded | [clm_CE8EF7EA3423](/claim/clm_CE8EF7EA3423.md)
- 2026-03-31 to 2026-06-30 | total_assets | 3,535,000,000 United States dollar | superseded | [clm_FAB71B669FE2](/claim/clm_FAB71B669FE2.md)
- 2026-03-31 to 2026-06-30 | total_equity | 2,395,000,000 United States dollar | superseded | [clm_FBF63F3E57F3](/claim/clm_FBF63F3E57F3.md)
- 2026-04-30 to 2026-07-31 | shares_outstanding | 235,029,814 shares | superseded | [clm_0C78558037D7](/claim/clm_0C78558037D7.md)
- 2026-06-30 | cash_and_equivalents | 757,000,000 United States dollar | valid | [clm_29FBBE0C38C0](/claim/clm_29FBBE0C38C0.md)
- 2026-06-30 | total_assets | 3,510,000,000 United States dollar | valid | [clm_587667A470E8](/claim/clm_587667A470E8.md)
- 2026-06-30 | quarterly_research_and_development | 202,000,000 United States dollar | valid | [clm_7E3210B95CA6](/claim/clm_7E3210B95CA6.md)
- 2026-06-30 | quarterly_revenue | 1,043,000,000 United States dollar | valid | [clm_9E93ADAFEE00](/claim/clm_9E93ADAFEE00.md)
- 2026-06-30 | quarterly_net_income | 111,000,000 United States dollar | valid | [clm_A9628A9A3B49](/claim/clm_A9628A9A3B49.md)
- 2026-06-30 | total_equity | 2,322,000,000 United States dollar | valid | [clm_AAE1D29860FF](/claim/clm_AAE1D29860FF.md)
- 2026-06-30 | quarterly_operating_income | 143,000,000 United States dollar | valid | [clm_C946D08A26E4](/claim/clm_C946D08A26E4.md)
- 2026-07-31 | shares_outstanding | 231,500,067 shares | valid | [clm_4C8ED5D90CFC](/claim/clm_4C8ED5D90CFC.md)
- 2026-10-25 | restructuring | Wind down Caper Cart operations to re-align resources to strategic priorities | valid | [clm_FF571413115C](/claim/clm_FF571413115C.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.